Cimetidine protects against acetaminophen hepatotoxicity in rats

M. C. Mitchell, S. Schenker, G. R. Avant, Kermit V Speeg

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Acetaminophen hepatotoxicity is believed to result from the metabolic conversion of acetaminophen to a highly reactive intermediate by cytochrome P450. Cimetidine has been shown to be a potent inhibitor of cytochrome P450-mediated drug metabolism in humans and in laboratory animals, both in vivo and in vitro. Therefore, this study was undertaken to examine the possible protective effects of cimetidine administration on acetaminophen-induced hepatic necrosis in rats. We observed a striking protection against acetaminophen hepatotoxicity in cimetidine-treated animals had less histologic damage when examined by light microscopy, and they had lower serum aminotransferase than those treated with acetaminophen alone. Furthermore, there was less functional hepatic impairment, e.g., improved survival and improved ability to metabolize aminopyrine in vivo in rats receiving cimetidine compared with those receiving acetaminophen without cimetidine. Comparison of cimetidine treatment with N-acetylcysteine treatment of acetaminophen overdose in rats showed cimetidine as effective as N-acetylcysteine, even though the dose of cimetidine given was only 1/15 th that of N-acetylcysteine on a molar basis. Cimetidine also inhibited the covalent binding of [3H]acetaminophen to hepatic microsomes in vitro, both in the presence and absence of reduced glutathione. Cimetidine did not, however, increase total hepatic glutathione stores within 4 h of its i.p. administration. Thus, we have shown that cimetidine effectively reduces acetaminophen hepatotoxicity in rats. Although the exact mechanism of its protective action is unproven, it seems likely that cimetidine inhibits the formation of the reactive metabolite of acetaminophen both in vivo and in vitro.

Original languageEnglish (US)
Pages (from-to)1052-1060
Number of pages9
JournalGastroenterology
Volume81
Issue number6
StatePublished - 1981
Externally publishedYes

Fingerprint

Cimetidine
Acetaminophen
Acetylcysteine
Liver
Cytochrome P-450 Enzyme System
Glutathione
Aminopyrine
Laboratory Animals
Microsomes
Transaminases
Microscopy
Necrosis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Mitchell, M. C., Schenker, S., Avant, G. R., & Speeg, K. V. (1981). Cimetidine protects against acetaminophen hepatotoxicity in rats. Gastroenterology, 81(6), 1052-1060.

Cimetidine protects against acetaminophen hepatotoxicity in rats. / Mitchell, M. C.; Schenker, S.; Avant, G. R.; Speeg, Kermit V.

In: Gastroenterology, Vol. 81, No. 6, 1981, p. 1052-1060.

Research output: Contribution to journalArticle

Mitchell, MC, Schenker, S, Avant, GR & Speeg, KV 1981, 'Cimetidine protects against acetaminophen hepatotoxicity in rats', Gastroenterology, vol. 81, no. 6, pp. 1052-1060.
Mitchell MC, Schenker S, Avant GR, Speeg KV. Cimetidine protects against acetaminophen hepatotoxicity in rats. Gastroenterology. 1981;81(6):1052-1060.
Mitchell, M. C. ; Schenker, S. ; Avant, G. R. ; Speeg, Kermit V. / Cimetidine protects against acetaminophen hepatotoxicity in rats. In: Gastroenterology. 1981 ; Vol. 81, No. 6. pp. 1052-1060.
@article{147e8418a8de441b946ffac0baaf264b,
title = "Cimetidine protects against acetaminophen hepatotoxicity in rats",
abstract = "Acetaminophen hepatotoxicity is believed to result from the metabolic conversion of acetaminophen to a highly reactive intermediate by cytochrome P450. Cimetidine has been shown to be a potent inhibitor of cytochrome P450-mediated drug metabolism in humans and in laboratory animals, both in vivo and in vitro. Therefore, this study was undertaken to examine the possible protective effects of cimetidine administration on acetaminophen-induced hepatic necrosis in rats. We observed a striking protection against acetaminophen hepatotoxicity in cimetidine-treated animals had less histologic damage when examined by light microscopy, and they had lower serum aminotransferase than those treated with acetaminophen alone. Furthermore, there was less functional hepatic impairment, e.g., improved survival and improved ability to metabolize aminopyrine in vivo in rats receiving cimetidine compared with those receiving acetaminophen without cimetidine. Comparison of cimetidine treatment with N-acetylcysteine treatment of acetaminophen overdose in rats showed cimetidine as effective as N-acetylcysteine, even though the dose of cimetidine given was only 1/15 th that of N-acetylcysteine on a molar basis. Cimetidine also inhibited the covalent binding of [3H]acetaminophen to hepatic microsomes in vitro, both in the presence and absence of reduced glutathione. Cimetidine did not, however, increase total hepatic glutathione stores within 4 h of its i.p. administration. Thus, we have shown that cimetidine effectively reduces acetaminophen hepatotoxicity in rats. Although the exact mechanism of its protective action is unproven, it seems likely that cimetidine inhibits the formation of the reactive metabolite of acetaminophen both in vivo and in vitro.",
author = "Mitchell, {M. C.} and S. Schenker and Avant, {G. R.} and Speeg, {Kermit V}",
year = "1981",
language = "English (US)",
volume = "81",
pages = "1052--1060",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Cimetidine protects against acetaminophen hepatotoxicity in rats

AU - Mitchell, M. C.

AU - Schenker, S.

AU - Avant, G. R.

AU - Speeg, Kermit V

PY - 1981

Y1 - 1981

N2 - Acetaminophen hepatotoxicity is believed to result from the metabolic conversion of acetaminophen to a highly reactive intermediate by cytochrome P450. Cimetidine has been shown to be a potent inhibitor of cytochrome P450-mediated drug metabolism in humans and in laboratory animals, both in vivo and in vitro. Therefore, this study was undertaken to examine the possible protective effects of cimetidine administration on acetaminophen-induced hepatic necrosis in rats. We observed a striking protection against acetaminophen hepatotoxicity in cimetidine-treated animals had less histologic damage when examined by light microscopy, and they had lower serum aminotransferase than those treated with acetaminophen alone. Furthermore, there was less functional hepatic impairment, e.g., improved survival and improved ability to metabolize aminopyrine in vivo in rats receiving cimetidine compared with those receiving acetaminophen without cimetidine. Comparison of cimetidine treatment with N-acetylcysteine treatment of acetaminophen overdose in rats showed cimetidine as effective as N-acetylcysteine, even though the dose of cimetidine given was only 1/15 th that of N-acetylcysteine on a molar basis. Cimetidine also inhibited the covalent binding of [3H]acetaminophen to hepatic microsomes in vitro, both in the presence and absence of reduced glutathione. Cimetidine did not, however, increase total hepatic glutathione stores within 4 h of its i.p. administration. Thus, we have shown that cimetidine effectively reduces acetaminophen hepatotoxicity in rats. Although the exact mechanism of its protective action is unproven, it seems likely that cimetidine inhibits the formation of the reactive metabolite of acetaminophen both in vivo and in vitro.

AB - Acetaminophen hepatotoxicity is believed to result from the metabolic conversion of acetaminophen to a highly reactive intermediate by cytochrome P450. Cimetidine has been shown to be a potent inhibitor of cytochrome P450-mediated drug metabolism in humans and in laboratory animals, both in vivo and in vitro. Therefore, this study was undertaken to examine the possible protective effects of cimetidine administration on acetaminophen-induced hepatic necrosis in rats. We observed a striking protection against acetaminophen hepatotoxicity in cimetidine-treated animals had less histologic damage when examined by light microscopy, and they had lower serum aminotransferase than those treated with acetaminophen alone. Furthermore, there was less functional hepatic impairment, e.g., improved survival and improved ability to metabolize aminopyrine in vivo in rats receiving cimetidine compared with those receiving acetaminophen without cimetidine. Comparison of cimetidine treatment with N-acetylcysteine treatment of acetaminophen overdose in rats showed cimetidine as effective as N-acetylcysteine, even though the dose of cimetidine given was only 1/15 th that of N-acetylcysteine on a molar basis. Cimetidine also inhibited the covalent binding of [3H]acetaminophen to hepatic microsomes in vitro, both in the presence and absence of reduced glutathione. Cimetidine did not, however, increase total hepatic glutathione stores within 4 h of its i.p. administration. Thus, we have shown that cimetidine effectively reduces acetaminophen hepatotoxicity in rats. Although the exact mechanism of its protective action is unproven, it seems likely that cimetidine inhibits the formation of the reactive metabolite of acetaminophen both in vivo and in vitro.

UR - http://www.scopus.com/inward/record.url?scp=0019407319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019407319&partnerID=8YFLogxK

M3 - Article

C2 - 7286583

AN - SCOPUS:0019407319

VL - 81

SP - 1052

EP - 1060

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 6

ER -